Combining anti-ERBB3 antibodies specific for domain I and domain III enhances the anti-tumor activity over the individual monoclonal antibodies.

by Jimson W D'Souza, Smitha Reddy, Lisa E Goldsmith, Irina Shchaveleva, James D Marks, Samuel Litwin, Matthew K Robinson
Published 2014-01-01

The Utility of Preoperative Vascular Grading in Patients Undergoing Surgery First for Pancreatic Cancer: Does Radiologic Arterial or Venous Involvement Predict Pathologic Margin St...

by Neha Goel, Jimson W. D’Souza, Karen J. Ruth, Barton Milestone, Andreas Karachristos, Rajeswari Nagarathinam, Harry Cooper, John Hoffman, Sanjay Reddy
Published 2018-01-01